Sulforaphane inhibits smooth muscle cell proliferation and migration by reducing MMP-9 activity via the Ras and RhoA/ROCK pathways

Journal of Functional Foods

Volumn 5, Issue 3, 2013, Pages 1097-1107

  Hung, Chi Nan ^a   Huang, Hui Pei ^b,c   Lii, Chong Kuei ^d   Liu, Kai Li ^b   Wang, Chau Jong ^b,c  

^a MINGDAO UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Matrix metalloproteinase 9; Migration; Proliferation; Sulforaphane; Vascular smooth muscle cell

Indexed keywords

EID: 84880511730     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.03.005     Document Type: Article

References (45)

1. Alvira C.M., Sukovich D.J., Lyu S.C., Cornfield D.N. Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cells. American Journal of Physiology Lung Cellular and Molecular Physiology 2010, 299:L872-878.
2. Angel K., Provan S.A., Gulseth H.L., Mowinckel P., Kvien T.K., Atar D. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: A controlled study. Hypertension 2010, 55:333-338.
3. Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Medical Journal 2004, 45:776-788.
4. Bond M., Fabunmi R.P., Baker A.H., Newby A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B. Federation of European Biochemical Societies (FEBS) Letters 1998, 435:29-34.
5. Booth A.D., Jayne D.R., Kharbanda R.K., McEniery C.M., Mackenzie I.S., Brown J., et al. Infliximab improves endothelial dysfunction in systemic vasculitis: A model of vascular inflammation. Circulation 2004, 109:1718-1723.
6. Butler S.M., Wallig M.A., Nho C.W., Pan C.H., Lee E.H., Jung S.H., et al. A polyacetylene-rich extract from Gymnaster koraiensis strongly inhibits colitis-associated colon cancer in mice. Food and Chemical Toxicology 2012, 53C:235-239.
7. Castro C., Lorenzo A.G., Gonzalez A., Cruzado M. Garlic components inhibit angiotensin II-induced cell-cycle progression and migration: Involvement of cell-cycle inhibitor p27(Kip1) and mitogen-activated protein kinase. Molecular Nutrition & Food Research 2010, 54:781-787.
8. Chien K.R., Hoshijima M. Unravelling ras signals in cardiovascular disease. Nature Cell Biology 2004, 6:807-808.
9. Chien K.R., Olson E.N. Converging pathways and principles in heart development and disease: CV@CSH. Cell 2002, 110:153-162.
10. Chu S.C., Chiou H.L., Chen P.N., Yang S.F., Hsieh Y.S. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Molecular Carcinogenesis 2004, 40:143-149.
11. Chung T.W., Lee Y.C., Kim C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: Involvement of invasive potential. Federation of American Societies for Experimental Biology (FASEB) Journal 2004, 18:1123-1125.
12. Cunningham K.S., Gotlieb A.I. The role of shear stress in the pathogenesis of atherosclerosis. Laboratory Investigation 2005, 85:9-23.
13. De Martin R., Hoeth M., Hofer-Warbinek R., Schmid J.A. The transcription factor NF-kappa B and the regulation of vascular cell function. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:E83-88.
14. Dong M., Yan B.P., Yu C.M. Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm. Cardiovascular & Hematological Agents in Medicinal Chemistry 2009, 7:322-330.
15. Elbarbry F., Elrody N. Potential health benefits of sulforaphane: A review of the experimental, clinical and epidemiological evidences and underlying mechanisms. Journal of Medicinal Plants Research 2011, 5:473-484.
16. Falk E. Pathogenesis of atherosclerosis. Journal of the American College of Cardiology 2006, 47:C7-12.
17. Fic P., Zakrocka I., Kurzepa J., Stepulak A. Matrix metalloproteinases and atherosclerosis. Postepy Higieny i Medycyny Doświadczalnej 2011, 65:16-27.
18. Fichtlscherer S., Rossig L., Breuer S., Vasa M., Dimmeler S., Zeiher A.M. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 2001, 104:3023-3025.
19. Fimognari C., Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutation Research 2007, 635:90-104.
20. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
21. Goncharova E.A., Ammit A.J., Irani C., Carroll R.G., Eszterhas A.J., Panettieri R.A., et al. PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. American Journal of Physiology Lung Cellular and Molecular Physiology 2002, 283:L354-L363.
22. Guerrero-Beltran C.E., Calderon-Oliver M., Pedraza-Chaverri J., Chirino Y.I. Protective effect of sulforaphane against oxidative stress: Recent advances. Experimental and Toxicologic Pathology 2012, 64:503-508.
23. Kang S.W., Kim J.L., Kwon G.T., Lee Y.J., Park J.H., Lim S.S., et al. Sensitive fern (Onoclea sensibilis) extract suppresses proliferation and migration of vascular smooth muscle cells inflamed by neighboring macrophages. Biological & Pharmaceutical Bulletin 2011, 34:1717-1723.
24. Kim J.Y., Park H.J., Um S.H., Sohn E.H., Kim B.O., Moon E.Y., et al. Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-alpha-stimulated mouse vascular smooth muscle cells: Involvement of the MAPK, NF-kappaB and AP-1 signaling pathways. Vascular Pharmacology 2011.
25. Lee E.J., Kim D.I., Kim W.J., Moon S.K. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. Molecular Nutrition & Food Research 2009, 53:1582-1591.
26. Loirand G., Rolli-Derkinderen M., Pacaud P. RhoA and resistance artery remodeling. American Journal of Physiology Heart and Circulatory Physiology 2005, 288:H1051-H1056.
27. Manchalia S., Murthy K.N.C., Patil B.S. Crucial facts about health benefits of popular cruciferous vegetables. Journal of Functional Foods 2012, 4:94-106.
28. Matusheski N.V., Jeffery E.H. Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. Journal of Agricultural and Food Chemistry 2001, 49:5743-5749.
29. Mirmiran P., Bahadoran Z., Hosseinpanah F., Keyzad A., Azizi F. Effects of broccoli sprout with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Journal of Functional Foods 2012, 4:837-841.
30. Moon S.K., Cha B.Y., Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. Journal of Cellular Physiology 2004, 198:417-427.
31. Moon S.K., Kim H.M., Lee Y.C., Kim C.H. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. The Journal of Biological Chemistry 2004, 279:33063-33070.
32. Myzak M.C., Ho E., Dashwood R.H. Dietary agents as histone deacetylase inhibitors. Molecular Carcinogenesis 2006, 45:443-446.
33. Noma K., Oyama N., Liao J.K. Physiological role of ROCKs in the cardiovascular system. American Journal of Physiology. Cell Physiology 2006, 290:C661-668.
34. Rectenwald J.E., Moldawer L.L., Huber T.S., Seeger J.M., Ozaki C.K. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000, 102:1697-1702.
35. Secchiero P., Zerbinati C., Rimondi E., Corallini F., Milani D., Grill V., et al. TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cellular and Molecular Life Sciences 2004, 61:1965-1974.
36. Stintzing S., Ocker M., Hartner A., Amann K., Barbera L., Neureiter D. Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis. Virchows Archiv 2009, 455:171-185.
37. Thejass P., Kuttan G. Antimetastatic activity of Sulforaphane. Life Sciences 2006, 78:3043-3050.
38. Tian Y., Autieri M.V. Cytokine expression and AIF-1-mediated activation of Rac2 in vascular smooth muscle cells: A role for Rac2 in VSMC activation. American Journal of Physiology. Cell Physiology 2007, 292:C841-849.
39. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Experimental Physiology 2005, 90:449-455.
40. Wang Z., Castresana M.R., Newman W.H. NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration. Federation of European Biochemical Societies (FEBS) Letters 2001, 508:360-364.
41. Wulf E., Deboben A., Bautz F.A., Faulstich H., Wieland T. Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:4498-4502.
42. Yeh C.-T., Yen G.-C. Chemopreventive functions of sulforaphane: A potent inducer of antioxidant enzymes and apoptosis. Journal of Functional Foods 2009, 1:23-32.
43. Yoon S.O., Shin S., Lee H.J., Chun H.K., Chung A.S. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Molecular Cancer Therapeutics 2006, 5:2666-2675.
44. Zhou Q., Liao J.K. Statins and cardiovascular diseases: From cholesterol lowering to pleiotropy. Current Pharmaceutical Design 2009, 15:467-478.
45. Zhou Q., Liao J.K. Pleiotropic effects of statins - basic research and clinical perspectives. Circulation Journal 2010, 74:818-826.